{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:44:32Z","timestamp":1787240672670,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.actatropica.2013.11.003","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T13:01:08Z","timestamp":1384347668000},"page":"112-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Combination therapy with nitazoxanide and amphotericin B, Glucantime\u00ae, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes"],"prefix":"10.1016","volume":"130","author":[{"given":"Juliana T.","family":"Mesquita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre G.","family":"Tempone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Q.","family":"Reim\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2013.11.003_bib0005","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0010","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/ajg.2011.306","article-title":"A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori","volume":"106","author":"Basu","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0015","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/AAC.00520-11","article-title":"The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase","volume":"55","author":"Carvalho","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0020","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jac\/dkp117","article-title":"Nitazoxanide, tizoxanide and a new analogue [4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide; NTB] inhibit the growth of kinetoplastid parasites (Trypanosoma cruzi and Leishmania mexicana) in vitro","volume":"63","author":"Chan-Bacab","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis \u2013 current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0030","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/AAC.00208-12","article-title":"Efficacy of combined therapy with liposome-encapsulated meglumineantimoniate and allopurinol in treatment of canine visceral leishmaniasis","volume":"56","author":"da Silva","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0035","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0040","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.4103\/0250-474X.99022","article-title":"Simultaneous voltammetric determination of nitazoxanide and ofloxacin in pharmaceutical formulation","volume":"73","author":"Gandhi","year":"2011","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0300-483X(95)03210-7","article-title":"Isobolographic analysis of interactions: an update on applications and utility","volume":"105","author":"Gessner","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.actatropica.2013.11.003_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jac\/45.4.453","article-title":"Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture","volume":"45","author":"Giacometti","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0060","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/AAC.01159-06","article-title":"Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni","volume":"51","author":"Hoffman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jac\/49.2.345","article-title":"Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species","volume":"49","author":"Lewis","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fmicb.2012.00286","article-title":"It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug","volume":"3","author":"Mesa-Arango","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2013.09.018","article-title":"Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum","author":"Mesquita","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2174\/092986707780362862","article-title":"Chemotherapy of leishmaniasis: past, present and future","volume":"14","author":"Mishra","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0085","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.bmcl.2011.02.100","article-title":"Synthesis of benzologues of Nitazoxanide and Tizoxanide: a comparative study of their in vitro broad-spectrum antiprotozoal activity","volume":"21","author":"Navarrete-Vazquez","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CPath.S821","article-title":"Pharmacotherapeutic options for visceral leishmaniasis \u2013 current scenario","volume":"2","author":"Pandey","year":"2009","journal-title":"Clin. Med. Pathol."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0100","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1128\/AAC.50.3.1112-1117.2006","article-title":"Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species","volume":"50","author":"Pankuch","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0105","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1590\/S0074-02762011000800022","article-title":"Investigation into in vitro anti-leishmanial combinations of calcium channel blockers and current anti-leishmanial drugs","volume":"106","author":"Reim\u00e3o","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2013.11.003_bib0110","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jac\/dkq542","article-title":"In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani","volume":"66","author":"Seifert","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0115","doi-asserted-by":"crossref","first-page":"e1629","DOI":"10.1371\/journal.pntd.0001629","article-title":"Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis","volume":"6","author":"Sharma","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1550-7408.1958.tb02565.x","article-title":"An eight-day method for screening compounds against Leishmania donovani in golden hamster","volume":"5","author":"Stauber","year":"1958","journal-title":"J. Protozool."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2013.11.003_bib0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","article-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2013.11.003_bib0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00436-010-1906-y","article-title":"In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani","volume":"107","author":"Zhang","year":"2010","journal-title":"Parasitol. Res."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X13003264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X13003264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T14:58:25Z","timestamp":1564671505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X13003264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":28,"alternative-id":["S0001706X13003264"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2013.11.003","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy with nitazoxanide and amphotericin B, Glucantime\u00ae, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2013.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}